Large-vessel vasculitis: Interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Lensen, K D F ^a   Comans, E F I ^b   Voskuyl, A E ^b   Van Der Laken, C J ^b   Brouwer, E ^c   Zwijnenburg, A T ^d   Pereira Arias Bouda, L M ^e   Glaudemans, A W J M ^c   Slart, R H J A ^c   Smulders, Y M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Department of Orthopaedic Surgery   (Netherlands)

^e RIJNLAND HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; BLOOD VESSEL WALL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FEMALE; FEMORAL ARTERY; FOLLOW UP; GIANT CELL ARTERITIS; HEPATIC ARTERY; HUMAN; LARGE VESSEL VASCULITIS; MAJOR CLINICAL STUDY; MALE; PET-CT SCANNER; RHEUMATIC POLYMYALGIA; SENSITIVITY AND SPECIFICITY; TEMPORAL ARTERITIS; VASCULITIS; ARTERY; ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; INFLAMMATION; OBSERVER VARIATION; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY;

AGED; ARTERIES; ATHEROSCLEROSIS; FEMALE; FLUORODEOXYGLUCOSE F18; GIANT CELL ARTERITIS; HUMANS; INFLAMMATION; MALE; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 84933038151     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/914692     Document Type: Article

References (38)

1. S. Basu, H. Zhuang, D. A. Torigian, J. Rosenbaum, W. Chen, and A. Alavi,"Functional imaging of inflammatory diseases using nuclear medicine techniques," Seminars in Nuclear Medicine, vol. 39, no. 2, pp. 124-145, 2009.
2. J. H. F. Rudd, K. S. Myers, S. Bansilal et al.,"Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations," Journal of NuclearMedicine, vol. 49, no. 6, pp. 871-878, 2008.
3. M. Fuchs, M. Briel, T. Daikeler et al.,"The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis," European Journal of NuclearMedicine andMolecular Imaging, vol. 39, no. 2, pp. 344-353, 2012.
4. K. Kösters, C. P. Bleeker-Rovers, R. van Crevel, W. J. G. Oyen, and A. J. A. M. van der Ven,"Aortitis diagnosed by F-18-fluorodeoxyglucose positron emission tomography in a patient with syphilis andHIV coinfection," Infection, vol. 33, no. 5-6, pp. 387-389, 2005.
5. T. Belhocine, D. Blockmans, R. Hustinx, J. Vandevivere, and L. Mortelmans,"Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data," European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 9, pp. 1305-1313, 2003.
6. S. Prieto-González, P. Arguis, A. García-Martínez et al.,"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography," Annals of the Rheumatic Diseases, vol. 71, no. 7, pp. 1170-1176, 2012.
7. A. Brack, V.Martinez-Taboada, A. Stanson, J. J. Goronzy, and C. M. Weyand,"Disease pattern in cranial and large-vessel giant cell arteritis," Arthritis & Rheumatology, vol. 42, no. 2, pp. 311-317, 1999.
8. P. C. Grayson, K. Maksimowicz-McKinnon, T. M. Clark et al.,"Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis," Annals of the Rheumatic Diseases, vol. 71, no. 8, pp. 1329-1334, 2012.
9. 18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of largevessel vasculitis," Clinical and Experimental Rheumatology, vol. 26, no. 3, supplement 49, pp. S47-S52, 2008.
10. P. Lehmann, S. Buchtala, N. Achajew et al.,"18F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans," Clinical Rheumatology, vol. 30, no. 1, pp. 37-42, 2011.
11. 18F]FDG PET and MRI," European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 5, pp. 730-736, 2003.
12. 18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease," European Journal ofNuclearMedicine and Molecular Imaging, vol. 32, no. 6, pp. 674-681, 2005.
13. D. Coggon, C.Martyn, K. T. Palmer, and B. Evanoff,"Assessing case definitions in the absence of a diagnostic gold standard," International Journal of Epidemiology, vol. 34, no. 4, pp. 949-952, 2005.
14. K.-J. D. F. Lensen, A. E. Voskuyl, C. J. van der Laken et al.,"18Ffluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin," PLoS ONE, vol. 8, no. 3, Article ID e58917, 2013.
15. G. G. Hunder, D. A. Bloch, B. A. Michel et al.,"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis," Arthritis and Rheumatism, vol. 33, no. 8, pp. 1122-1128, 1990.
16. R. Boellaard, M. J. O'Doherty, W. A. Weber et al.,"FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0," European Journal of NuclearMedicine and Molecular Imaging, vol. 37, no. 1, pp. 181-200, 2010.
17. T. A. Kermani, E. L. Matteson, G. G. Hunder, and K. J. Warrington,"Symptomatic lower extremity vasculitis in giant cell arteritis: a case series,"The Journal of Rheumatology, vol. 36, no. 10, pp. 2277-2283, 2009.
18. D. M. Nuenninghoff, G. G. Hunder, T. J. H. Christianson, R. L. McClelland, and E. L. Matteson,"Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or largeartery stenosis) in patientswith giant cell arteritis: a populationbased study over 50 years," Arthritis & Rheumatism, vol. 48, no. 12, pp. 3532-3537, 2003.
19. J. R. Landis and G. G. Koch,"The measurement of observer agreement for categorical data," Biometrics, vol. 33, no. 1, pp. 159-174, 1977.
20. R Foundation for Statistical Computing, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2012.
21. D. Blockmans, S. Stroobants, A. Maes, and L. Mortelmans,"Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch," American Journal of Medicine, vol. 108, no. 3, pp. 246-249, 2000.
22. D. Blockmans, C. L. De, S. Vanderschueren, D. Knockaert, L. Mortelmans, and H. Bobbaers,"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients," Arthritis & Rheumatism, vol. 55, no. 1, pp. 131-137, 2006.
23. N. D. Papathanasiou, Y. Du, L. J. Menezes et al.," 18FFludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters," The British Journal of Radiology, vol. 85, no. 1014, pp. e188-e194, 2012.
24. M. Brodmann, R.W. Lipp, A. Passath, G. Seinost, E. Pabst, and E. Pilger,"The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries," Rheumatology (Oxford), vol. 43, no. 2, pp. 241-242, 2004.
25. A. K. Scheel, J. Meller, R. Vosshenrich et al.,"Diagnosis and follow up of aortitis in the elderly," Annals of the Rheumatic Diseases, vol. 63, no. 11, pp. 1507-1510, 2004.
26. M. Both, K. Hmadi-Simab, M. Reuter et al.,"MRI and FDGPET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis," Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 1030-1033, 2008.
27. C. Agard, J. H. Barrier, B. Dupas et al.,"Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan," Arthritis & Rheumatism, vol. 59, no. 5, pp. 670-676, 2008.
28. I. Marie, A. Proux, P. Duhaut et al.,"Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients," Medicine (Baltimore), vol. 88, no. 3, pp. 182-192, 2009.
29. W. A. Schmidt, A. Natusch, D. E. Moller, K. Vorpahl, and E. Gromnica-Ihle,"Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study," Clinical and Experimental Rheumatology, vol. 20, no. 3, pp. 309-318, 2002.
30. W. A. Schmidt, A. Seifert, E. Gromnica-Ihle, A. Krause, and A. Natusch,"Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis," Rheumatology (Oxford), vol. 47, no. 1, pp. 96-101, 2008.
31. M. E. De, C. Castillo, A. Rodriguez, and J. J. De Agustin,"Learning and reliability of colour Doppler ultrasound in giant cell arteritis," Clinical and Experimental Rheumatology, vol. 27, no. 1, supplement 52, pp. S53-S58, 2009.
32. J. Narvaez, J. A. Narvaez, J. M. Nolla, E. Sirvent, D. Reina, and J. Valverde,"Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis," Rheumatology (Oxford), vol. 44, no. 4, pp. 479-483, 2005.
33. M. Koenigkam-Santos, P. Sharma, B. Kalb et al.,"Magnetic resonance angiography in extracranial giant cell arteritis," Journal of Clinical Rheumatology, vol. 17, no. 6, pp. 306-310, 2011.
34. K. M. Mäki-Petäjä, M. Elkhawad, J. Cheriyan et al.,"Antitumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis," Circulation, vol. 126, no. 21, pp. 2473-2480, 2012.
35. A. L. Figueroa, S. S. Subramanian, R. C. Cury et al.,"Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features a comparison between positron emission tomography activity, plaque morphology, and histopathology," Circulation: Cardiovascular Imaging, vol. 5, no. 1, pp. 69-77, 2012.
36. J. H. F. Rudd, K. S. Myers, S. Bansilal et al.,"Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positronemission tomography/computed tomography imaging study," Circulation: Cardiovascular Imaging, vol. 2, no. 2, pp. 107-115, 2009.
37. S. S. Silvera, H. E. Aidi, J. H. F. Rudd et al.,"Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries," Atherosclerosis, vol. 207, no. 1, pp. 139-143, 2009.
38. A. Rominger, T. Saam, S. Wolpers et al.,"18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease," Journal of Nuclear Medicine, vol. 50, no. 10, pp. 1611-1620, 2009.